Status:

COMPLETED

Transcorneal Electrical Stimulation - Multicenter Safety Study

Lead Sponsor:

Okuvision GmbH

Conditions:

Retinitis Pigmentosa

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The purpose of this study is to expand the safety assessment of repeated applications of an electrical current from a DTL-like electrode in patients with RP.

Detailed Description

This is a single-arm open label interventional safety trial with RP patients, who receive weekly TES for 6 months on 1 eye followed by observation for another 6 months without stimulation. The primary...

Eligibility Criteria

Inclusion

  • patients with retinitis pigmentosa (rod-cone dystrophy) after prescription of electrical stimulation by an ophthalmologist
  • adult patients who are capable of giving consent,
  • Visual acuity ≥ 0.02
  • because the electrode is to be positioned on the eye at home, the patient or his family members should have sufficient fine motor skills (assessment by the study physician)
  • the patient must be capable of giving consent and a medical assessment that he/she is able to participate in the whole study according to the protocol

Exclusion

  • diabetic retinopathy
  • neovascularisation of any origin
  • after arterial or venous occlusion
  • after retinal detachment
  • silicone oil tamponade
  • dry or exudative age-related macular degeneration
  • macular edema
  • all forms of glaucoma
  • any form of corneal degeneration that reduces visual acuity
  • systemic diseases that are difficult to control or manage, that could endanger the normal study schedule
  • patients in a permanently poor general condition, which could hinder the regular attendance at control examinations in the clinic
  • forms of mental illness related to the bipolar affective and schizoid-affective disorders, and all forms of dementia
  • simultaneous participation in another interventional study or history of interventions whose effect may still persist

Key Trial Info

Start Date :

September 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2015

Estimated Enrollment :

105 Patients enrolled

Trial Details

Trial ID

NCT01835002

Start Date

September 1 2012

End Date

August 1 2015

Last Update

March 4 2021

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Glostrup Hospital and Kennedy Center

Glostrup Municipality, Denmark

2

University Eye Clinic Bonn

Bonn, Germany, 53127

3

Augenzentrum München

Munich, Germany

4

University Eye Clinic Regensburg

Regensburg, Germany, 93053